methazolamide NDC 0574-0790

NDC codes

FDA NDC Directory

Product NDC (as listed)0574-0790Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00574-0790Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0574-0790-01	00574079001	100 TABLET in 1 BOTTLE, PLASTIC (0574-0790-01)Marketed from Sep 30, 2014

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): methazolamide
Generic name (nonproprietary): methazolamide
Active ingredients: Methazolamide — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Padagis US LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040062
Marketing start: Sep 30, 2014
Marketing end: Sep 30, 2027
Identifiers: Product ID 0574-0790_94b58ed4-5a45-4777-924c-7608156be1b0SPL ID 94b58ed4-5a45-4777-924c-7608156be1b0SPL set ID 5e0795e1-d5c5-4b04-9bce-077bb8028023RxCUI 197939, 197940UNII W733B0S9SDUPC 0305740790014, 0305740791011

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400574079001 followed by a unit qualifier and the quantity

Package 00574-0790-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE: Methazolamide Tablets USP is indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040062

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040062
Product	Strength	Form · route	Labeler	Product NDC
methazolamide	Methazolamide 50 mg/1	TabletOral	Padagis US LLC	0574-0791